Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katherine A Janeway

Showing results (1-10 of 144) with videos related to

Pageof 15
Sort By:
Journal of Pediatric Hematology/Oncology|April 25, 2012
Treatment guidelines for gastrointestinal stromal tumors in children and young adultsKatherine A Janeway, Alberto Pappo
The Lancet. Oncology|March 30, 2010
Sequelae of osteosarcoma medical therapy: a review of rare acute toxicities and late effectsKatherine A Janeway, Holcombe E Grier
Hematology/Oncology Clinics of North America|March 3, 2009
Pediatric gastrointestinal stromal tumorsAlberto S Pappo, Katherine A Janeway
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 30, 2012
New strategies in sarcoma therapy: linking biology and novel agentsKatherine A Janeway, Robert G Maki
Seminars in Pediatric Surgery|January 18, 2012
Pediatric gastrointestinal stromal tumorKatherine A Janeway, Christopher B Weldon
Bone|August 11, 2010
Modeling human osteosarcoma in the mouse: From bedside to benchKatherine A Janeway, Carl R Walkley
F1000Research|July 22, 2016
Emerging concepts for PI3K/mTOR inhibition as a potential treatment for osteosarcomaMichael W Bishop, Katherine A Janeway
Current Opinion in Pediatrics|December 1, 2017
Precision medicine in pediatric oncologySuzanne J Forrest, Birgit Geoerger, Katherine A Janeway
Current Opinion in Pediatrics|December 3, 2015
Future directions in the treatment of osteosarcomaMichael W Bishop, Katherine A Janeway, Richard Gorlick
Sarcoma|August 31, 2018
Comparison of Epidemiology, Clinical Features, and Outcomes of Patients with Reported Ewing Sarcoma and PNET over 40 Years Justifies Current WHO Classification and Treatment ApproachesKevin Campbell, David Shulman, Katherine A Janeway, et al.
Pageof 15

Showing results (1-10 of 144) with videos related to

Sort By:
Pageof 15
Journal of Pediatric Hematology/Oncology|April 25, 2012
Treatment guidelines for gastrointestinal stromal tumors in children and young adultsKatherine A Janeway, Alberto Pappo
The Lancet. Oncology|March 30, 2010
Sequelae of osteosarcoma medical therapy: a review of rare acute toxicities and late effectsKatherine A Janeway, Holcombe E Grier
Hematology/Oncology Clinics of North America|March 3, 2009
Pediatric gastrointestinal stromal tumorsAlberto S Pappo, Katherine A Janeway
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 30, 2012
New strategies in sarcoma therapy: linking biology and novel agentsKatherine A Janeway, Robert G Maki
Seminars in Pediatric Surgery|January 18, 2012
Pediatric gastrointestinal stromal tumorKatherine A Janeway, Christopher B Weldon
Bone|August 11, 2010
Modeling human osteosarcoma in the mouse: From bedside to benchKatherine A Janeway, Carl R Walkley
F1000Research|July 22, 2016
Emerging concepts for PI3K/mTOR inhibition as a potential treatment for osteosarcomaMichael W Bishop, Katherine A Janeway
Current Opinion in Pediatrics|December 1, 2017
Precision medicine in pediatric oncologySuzanne J Forrest, Birgit Geoerger, Katherine A Janeway
Current Opinion in Pediatrics|December 3, 2015
Future directions in the treatment of osteosarcomaMichael W Bishop, Katherine A Janeway, Richard Gorlick
Sarcoma|August 31, 2018
Comparison of Epidemiology, Clinical Features, and Outcomes of Patients with Reported Ewing Sarcoma and PNET over 40 Years Justifies Current WHO Classification and Treatment ApproachesKevin Campbell, David Shulman, Katherine A Janeway, et al.
Pageof 15